Adseverin, a member of the gelsolin/villin family of actin severing and capping proteins, plays a pivotal role in the dynamic regulation of the actin cytoskeleton. It is involved in various cellular processes including cell motility, secretion, and membrane trafficking. Adseverin functions by binding to actin filaments, severing them, and then capping the fast-growing ends, which prevents further polymerization of actin monomers at these ends. This actin filament remodeling is crucial for the rapid reorganization of the cytoskeleton in response to cellular signals and environmental cues, facilitating changes in cell shape and the formation of membrane protrusions required for cell movement and the endocytic and exocytic vesicle trafficking. The activity of adseverin is thus integral to the maintenance of cellular dynamics and architecture, impacting a range of physiological processes from tissue development to immune response.
The inhibition of adseverin involves mechanisms that directly or indirectly reduce its actin-severing and -capping activities. One approach to inhibit adseverin's function is through the modulation of calcium ions (Ca2+) concentration, as its activity is highly dependent on Ca2+ binding. Without sufficient Ca2+ levels, adseverin cannot undergo the conformational changes required for actin interaction and subsequent filament severing. Furthermore, post-translational modifications of adseverin, such as phosphorylation, can alter its affinity for actin or its severing activity, serving as another regulatory mechanism. Additionally, the expression of adseverin can be downregulated at the transcriptional level by specific signaling pathways or transcription factors, which ultimately decreases its abundance and activity within the cell. These inhibitory mechanisms ensure that the actin cytoskeleton's structure and dynamics can be finely tuned according to the cell's needs, highlighting the complexity of cellular regulation and the critical role of adseverin in cytoskeletal organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Calcium channel blocker that can reduce intracellular calcium, potentially affecting adseverin's calcium-dependent actin-severing function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Influences intracellular calcium release, which might indirectly modulate adseverin activity. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds actin monomers and prevents their polymerization, which can indirectly influence adseverin's interaction with actin. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization and can interfere with actin filament dynamics, potentially affecting adseverin-mediated severing. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Stabilizes actin filaments, potentially countering the severing effect of adseverin. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium and can indirectly influence calcium-dependent processes including adseverin activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another calcium channel blocker that can reduce intracellular calcium levels. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and can reduce actin dynamics, potentially countering adseverin's severing activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) leading to a rise in cytosolic calcium concentrations. | ||||||